Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Quality testing claims
By increasing vessel formation by over 100%, BPC-157 can potentially overcome this anatomical limitation and improve the delivery of healing factors to damaged tissue
Its versatility allows it to be used in a variety of procedures, ranging from intramuscular to intravenous injections
Cardiovascular Protection Myocardial infarction Protected against isoprenaline-induced MI in rats, with reduced cardiac damage markers Pulmonary hypertension Both prevented and reversed monocrotaline-induced pulmonary hypertension in rats Arrhythmias Antiarrhythmic effects, including counteracting digitalis-induced ventricular tachycardia Thrombosis Prevention and reversal demonstrated in animal models (PMID: 36359218) Liver Protection Hepatoprotective effects Protected against liver damage from restraint stress, bile duct ligation, hepatic artery ligation, and carbon tetrachloride (CCl4) toxicity (PMID: 7901724) Radiation-induced liver injury Reduced apoptosis and lipid accumulation via KLF4 upregulation (PMID: 36228773) Alcohol-related damage Attenuated liver lesions in chronic alcohol models For practical information on how researchers have applied these findings, see our BPC-157 Dosing Guide and BPC-157 Results Timeline
US$ 28.81
US$ 20.95
US$ 23.75
US$ 28.64
US$ 22.34
